Nepanil (Escitalopram)

Escitalopram, the active ingredient in Nepanil, is a selective serotonin reuptake inhibitor presented as an oral formulation for oral use. It is prescribed for major depressive disorder and several anxiety‑related conditions in adult patients. It is indicated for the treatment of major depressive disorder, generalized anxiety disorder, panic disorder, social anxiety disorder, and obsessive‑compulsive disorder, improving mood and anxiety symptoms through serotonergic modulation.

GNH USA supplies Nepanil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Escitalopram acts on the serotonergic pathway and is used to manage several mood and anxiety disorders in adult patients. - Major depressive disorder: reduces depressive symptoms and improves overall mood. - Generalized anxiety disorder: alleviates excessive worry and associated physical tension. - Panic disorder: decreases frequency and intensity of panic attacks. - Social anxiety disorder: lessens fear of social situations and improves functional performance. - Obsessive‑compulsive disorder: diminishes obsessive thoughts and compulsive behaviors.

Escitalopram may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Nausea - Headache - Insomnia or somnolence - Decreased libido or sexual dysfunction

Serious or Rare Side Effects: - Serotonin syndrome (potentially life‑threatening) - Suicidal ideation, especially in patients under 25 - Severe allergic reactions such as anaphylaxis

Before and during treatment with Nepanil, several precautions should be observed. - Assess psychiatric history: evaluate for suicidal thoughts before initiating therapy. - Monitor for serotonin syndrome: watch for agitation, hyperthermia, tremor, and autonomic instability. - Use caution in patients with hepatic impairment: dose adjustment may be required. - Avoid abrupt discontinuation: taper gradually under medical supervision to prevent withdrawal symptoms. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Escitalopram can interact with other medicines; awareness of the interaction level helps manage risk.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome. - Pimozide: can cause QT prolongation and arrhythmias. - Certain antiarrhythmics (e.g., quinidine): increase escitalopram plasma levels.

Moderate Interactions (Monitor Closely): - NSAIDs and antiplatelet agents: may increase bleeding risk. - CYP2C19 inhibitors (e.g., fluoxetine, omeprazole): may raise escitalopram concentrations. - Alcohol: can enhance CNS depression and side effects.